Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Minimal Residual Disease Detection with Urine-derived DNA Is Prognostic for Recurrence-free Survival in Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer Treated with Nadofaragene Firadenovec.
Narayan VM, Tholomier C, Mokkapati S, Martini A, Caruso VM, Goudarzi M, Mazzarella BC, Phillips KG, Bicocca VT, Levin TG, Yla-Herttuala S, McConkey DJ, Dinney CPN. Narayan VM, et al. Among authors: phillips kg. Eur Urol Oncol. 2024 Oct 14:S2588-9311(24)00225-6. doi: 10.1016/j.euo.2024.09.016. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39406613 Free article.
Urinary comprehensive genomic profiling predicts urothelial carcinoma recurrence and identifies responders to intravesical therapy.
Rac G, Patel HD, James C, Desai S, Caruso VM, Fischer DS, Lentz PS, Ward CT, Mazzarella BC, Phillips KG, Doshi C, Bicocca VT, Levin TG, Wolfe AJ, Gupta GN. Rac G, et al. Among authors: phillips kg. Mol Oncol. 2024 Feb;18(2):291-304. doi: 10.1002/1878-0261.13530. Epub 2023 Oct 5. Mol Oncol. 2024. PMID: 37753732 Free PMC article.
Development and Multicenter Case-Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction.
Salari K, Sundi D, Lee JJ, Wu S, Wu CL, DiFiore G, Yan QR, Pienkny A, Lee CK, Oberlin D, Barme G, Piser J, Kahn R, Collins E, Phillips KG, Caruso VM, Goudarzi M, Garcia-Ransom M, Lentz PS, Evans-Holm ME, MacBride AR, Fischer DS, Haddadzadeh IJ, Mazzarella BC, Gray JW, Koppie TM, Bicocca VT, Levin TG, Lotan Y, Feldman AS. Salari K, et al. Among authors: phillips kg. Clin Cancer Res. 2023 Sep 15;29(18):3668-3680. doi: 10.1158/1078-0432.CCR-23-0570. Clin Cancer Res. 2023. PMID: 37439796 Free PMC article.
Erratum to "How different experimental models of secondary hyperalgesia change the nociceptive flexion reflex" [Clin. Neurophysiol. 132 (2021) 2989-2995].
Leone C, Di Lionardo A, Di Pietro G, Di Stefano G, Falco P, Blockeel AJ, Caspani O, Garcia-Larrea L, Mouraux A, Phillips KG, Treede RD, Truini A. Leone C, et al. Among authors: phillips kg. Clin Neurophysiol. 2023 Jan;145:162. doi: 10.1016/j.clinph.2022.07.499. Epub 2022 Nov 7. Clin Neurophysiol. 2023. PMID: 36357284 Free article. No abstract available.
83 results